Korean J Transplant.  2022 Nov;36(Supple 1):S188. 10.4285/ATW2022.F-3148.

The impact of early tacrolimus exposure to long-term renal function and growth in pediatric liver transplant recipients

• Wong HW
• Lam Wong TC

• KMID: 2535704
• DOI: http://doi.org/10.4285/ATW2022.F-3148

Abstract

Background
Life-long immunosuppression is required for liver transplant (LT) recipients to prevent graft rejection. This study aimed to analyze the effect of early calcineurin inhibitor exposure to the long-term outcomes of pediatric recipients.
Methods
This was a retrospective study from a university center. Pediatric patients (age <11-year-old at time of LT) and had regular follow-up, from 2001 to 2018 were included. All tacrolimus (TAC) trough level within the first year after LT were plotted against time and the area under curve was defined as total TAC exposure. Patients were divided into high and low TAC exposure according to the median TAC exposure.
Results
Eighty-five patients were included (high TAC, n=42; low TAC, n=43). The TAC exposure of the two groups became similar from third to fifth year after LT. The estimated glomerular filtration rate at 5-, 10- and 15-year after LT were 107.6 vs. 116.0, 111.9 vs. 117.8 and 98.7 vs. 118.3 in the high and low TAC group respectively although there was no difference in serum creat-inine level. Long-term complication rates for ACR, OI and PTLD were similar in both groups (11.9% vs. 7.0% and 2.4% vs. 2.3% and 26.2% vs. 18.6%). Growth of LT recipients was comparable to the general population and there was no difference between the two groups for body weight, height and body mass index. There was no difference in the incidence of other metabolic complications including hypertension, dyslipidemia and diabetes and the risk remains very low in the long run (0%–2.4%).
Conclusions
Early TAC exposure is detrimental to the long-term renal function of pediatric recipients while the risk of ACR, opportunistic infection and graft survival were similar. TAC exposure should be reduced early after LT as long as graft function allows, in order to preserve long-term renal function.